福沙匹坦二甲葡胺

• 常用名: 福沙匹坦二甲葡胺
• 英文名: Fosaprepitant dimeglumine salt
• CAS号: 265121-04-8
• 分子量: 1004.83000
• 密度: N/A
• 沸点: N/A
• 分子式: C₃₇H₅₆F₇N₆O₁₆P
• 熔点: N/A
• 闪点: N/A

福沙匹坦二甲葡胺用途

Fosaprepitant dimeglumine(MK-0517)是神经激肽-1受体拮抗剂,可作用于化疗引起的恶心呕吐。

福沙匹坦二甲葡胺名称

• 中文名: 福沙吡坦二甲葡胺
• 英文名: fosaprepitant dimeglumine

福沙匹坦二甲葡胺生物活性

• 描述: Fosaprepitant dimeglumine(MK-0517)是神经激肽-1受体拮抗剂,可作用于化疗引起的恶心呕吐。
• 相关类别:
  信号通路 >> G 蛋白偶联受体/G 蛋白 >> 神经激肽受体
  信号通路 >> 神经信号通路 >> 神经激肽受体
  研究领域 >> 神经疾病
• 参考文献:

  [1]. Navari RM. Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting. Expert Rev Anticancer Ther. 2008 Nov;8(11):1733-42.

  [2]. Olver IN. Prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitant. Ther Clin Risk Manag. 2008 Apr;4(2):501-6.

  [3]. Grunberg S, et al. Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with cisplatin therapy: randomized, double-blind study protocol--EASE. J Clin Oncol. 2011 Apr 10;29(11):1495-501.

  [4]. Saito H, et al. Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. Ann Oncol. 2013 Apr;24(4):1067-73.

福沙匹坦二甲葡胺物理化学性质

• 分子式: C₃₇H₅₆F₇N₆O₁₆P
• 分子量: 1004.83000
• 精确质量: 1004.34000
• PSA: 366.08000
• InChIKey: VRQHBYGYXDWZDL-OOZCZQCLSA-N
• SMILES: CC(OC1OCCN(Cc2nn(P(=O)(O)O)c(=O)[nH]2)C1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1.CNCC(O)C(O)C(O)C(O)CO.CNCC(O)C(O)C(O)C(O)CO
• 储存条件: -20°C

福沙匹坦二甲葡胺安全信息

• 危害码 (欧洲): Xi

福沙匹坦二甲葡胺靶点实验

查看更多实验

实验名称：Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VER... 来源：ChEMBL 靶标：Severe acute respiratory syndrome coronavirus 2 External Id：CHEMBL4513082

实验名称：HTS to identify compounds that affect the blood-brain barrier permeability in vitro 来源：26908 靶标：N/A External Id：HTS97080

实验名称：Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Cac... 来源：ChEMBL 靶标：Severe acute respiratory syndrome coronavirus 2 External Id：CHEMBL4303805

实验名称：SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response f... 来源：ChEMBL 靶标：Replicase polyprotein 1ab External Id：CHEMBL4495582

共4条，当前第1页，共1页

1

福沙匹坦二甲葡胺英文别名

• Ivemend
• phosphonic acid, [3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]-, compd. with D-glucitol, 1-deoxy-1-(m
• phosphonic acid, [3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]-, compd. with D-glucitol, 1-deoxy-1-(methylamino)- (1:2)
• acide (3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluorométhyl)phényl]éthoxy}-3-(4-fluorophényl)morpholin-4-yl]méthyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonique - (2R,3R,4R,5S)-6-(méthylamino)hexane
• [5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-3-oxo-1H-1,2,4-triazol-2-yl]phosphonic acid,(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
• (3-{[(2R,3S)-2-{(1R)-1-[3,5-Bis(trifluormethyl)phenyl]ethoxy}-3-(4-fluorphenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonsäure--(2R,3R,4R,5S)-6-(methylamino)hexan-1,2,3,4,5-pentol(1:2)
• (3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid - (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol (1:2)
• acide (3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluorométhyl)phényl]éthoxy}-3-(4-fluorophényl)morpholin-4-yl]méthyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonique - (2R,3R,4R,5S)-6-(méthylamino)hexane-1,2,3,4,5-pentol (1:2)
• fosaprepitant dimeglumine
• Fosaprepitant dimeglumine (USAN)
• Proemend (TN)
• (3-{[(2R,3S)-2-{(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)-4-morpholinyl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:2)
• Phosphonic acid, [3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-4,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]-, compd. with D-glucitol, 1-deoxy-1-(methylamino)- (1:2)
• MK-0517
• (3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:2)
• UNII-D35FM8T64X
• Fosaprepitant dimeglumine salt
• Fosaprepitant meglumine
• Fosaprepitant (dimeglumine)